Cara Therapeutics | CARA - Ativo Circulante

Preço das Ações
3.60
Mudança Diária
0.08 2.27%
Mensal
-3.74%
Anual
-78.65%
Q1 Previsão
3.41




Ativo Circulante Alterar Data
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
Alterity Therapeutics Limited AUD 27.05M 6.16M 2023-06
Assertio Holdings USD 263.57M 53.36M 2025-09
Cara Therapeutics USD 43.13M 4.18M 2025-06
Cassava Sciences USD 97.71M 11.2M 2025-12
Chugai Pharma JPY 1.74T 223.03B 2025-12
Cipla INR 249.18B 16.3B 2025-09
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 148.02M 59.1M 2025-12
CSL USD 11.85B 1000K 2025-12
Grifols EUR 5.96B 316.31M 2025-12
Halozyme Therapeutics USD 825.21M 503.54M 2025-12
J&J USD 55.62B 1.01B 2025-12
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Pacira USD 547.97M 14.78M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
RedHill Biopharma USD 12.56M 644K 2025-06
Supernus Pharmaceuticals USD 644.18M 50.29M 2025-12
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12